Plaintiffs contend the FDAs failure to act as of date has everything to do with the lack of a pain or fever reducer available to pregnant women and their fear that such women will be deterred from taking acetaminophen when the benefit (reducing maternal fever) would exceed potential risks (developmental disorder)
By healing the gut lining, reducing intestinal permeability, and modulating gut inflammation, BPC-157 addresses the peripheral inflammatory signaling that contributes to central neuroinflammation and depressive symptoms
Eur J Pharmacol 589:306314
Oral GLP-1s require strict fasting and timing protocols, while most injections are taken once weekly without food restrictions
Potential Side Effects Common side effects include: Dizziness Fatigue Gastrointestinal issues (such as diarrhea, constipation, and gassiness) Headache Stomach issues (including nausea, vomiting, pain, or distension) Gastrointestinal issues are the most common complaint, especially when starting Semaglutide
